HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.

Abstract
U-89843 is a novel pyrrolo[2,3-d]pyrimidine antioxidant with prophylactic activity in animal models of lung inflammation. During preclinical safety evaluation, U-89843 was found to give a positive response in the in vitro unscheduled DNA synthesis (UDS) assay, an assay which measures DNA repair following chemically-induced DNA damage in metabolically competent rat hepatocytes. Incubation of [14C]U-89843 with liver microsomes resulted in covalent binding of radioactive material to macromolecules by a process that was NADPH-dependent. U-89843 has been shown to undergo C-6 methylhydroxylation to give U-97924, in rat both in vivo and in vitro, in a reaction catalyzed by cytochrome P450 2C11. Synthetical U-97924 is chemically reactive and undergoes dimerization in aqueous solution. The dimerization of U-97924 was significantly inhibited by addition of nucleophiles such as methanol, glutathione, and N-acetylcysteine. Characterization of the corresponding methanol, glutathione, and N-acetylcysteine adducts of U-97924 supported the hypothesis of a reaction pathway involving reactive iminium species formed via dehydration of U-97924. The metabolism-dependent irreversible covalent binding of radioactive material to liver microsomal protein and DNA also is dramatically reduced in the presence of reduced glutathione (GSH). A trifluoromethyl analog of U-89843 was prepared in an effort to block the corresponding metabolic hydroxylation pathway. This new compound (U-107634) was found to be negative in the in vitro UDS assay, and its metabolic susceptibility toward hydroxylation at the C-6 methyl group was eliminated. These observations suggest that the positive in vitro UDS results of U-89843 are mediated by the bioactivation of U-89843, leading to reactive electrophilic intermediates derived from the (hydroxymethyl)pyrrole metabolite U-97924.
AuthorsZ Zhao, K A Koeplinger, G E Padbury, M J Hauer, G L Bundy, L S Banitt, T M Schwartz, D C Zimmermann, P R Harbach, J K Mayo, C S Aaron
JournalChemical research in toxicology (Chem Res Toxicol) Vol. 9 Issue 8 Pg. 1230-9 (Dec 1996) ISSN: 0893-228X [Print] United States
PMID8951224 (Publication Type: Journal Article)
Chemical References
  • Free Radical Scavengers
  • Mutagens
  • Pyrimidines
  • Pyrroles
  • U 89843
Topics
  • Animals
  • Biotransformation
  • Chromatography, High Pressure Liquid
  • DNA Repair
  • Dogs
  • Free Radical Scavengers (chemistry, metabolism, toxicity)
  • Gas Chromatography-Mass Spectrometry
  • Haplorhini
  • Humans
  • In Vitro Techniques
  • Male
  • Microsomes, Liver (metabolism)
  • Mutagens (chemistry, metabolism, toxicity)
  • Protein Binding
  • Pyrimidines (chemistry, metabolism, toxicity)
  • Pyrroles (chemistry, metabolism, toxicity)
  • Rats
  • Rats, Inbred F344
  • Spectrometry, Mass, Fast Atom Bombardment
  • Spectrophotometry, Ultraviolet

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: